Company intelligence / Profile preview

Vetter

Des Plaines, Illinois, United Statesvetter-pharma.com ↗

Ownership: Private
Employees: ~7000
Development stage: Commercial

Overview

Provides end-to-end support for injectable drug product development from preclinical through commercial stages. No proprietary clinical results as it does not develop its own therapeutics.

Modalities: PeptidesMonoclonal antibodyFusion proteinVaccine (non-live)OligonucleotideMicroparticle formulationSmall molecule (inferred from broad CDMO services)
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Vetter.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vetter.

Explore the full profile